JosephClaytonGatheJr.MDFACP FIDSA

PubMed

• 8 citations
  Efficacy, Pharmacokinetics, and Safety Over 48 Weeks With Ibalizumab-Based Therapy in Treatment-Experienced Adults Infected With HIV-1: A Phase 2a Study.
  Joseph Gathe, Robin L Hardwicke, Fernando Garcia, Steven Weinheimer, Stanley T. Lewis, Robert Brandon Cash> ;Journal of Acquired Immune Deficiency Syndromes. 2021 Apr 1
• 1 citations
  Vitamin D Assessment Over 48 Weeks in Treatment-Naive HIV Individuals Starting Lopinavir/Ritonavir Monotherapy.
  Rustin D. Crutchley, David M. Jacobs, Joseph Gathe, Carl Mayberry, Nataliya Bulayeva, Kevin P. Rosenblatt, Kevin W. Garey> ;Current HIV Research. 2021 Jan 1
• 19 citations
  Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the...
  Gregory D Huhn, Gordon Crofoot, Moti Ramgopal, Joseph Gathe, Robert K. Bolan, Donghan Luo, Richard Bruce Simonson, Richard E. Nettles, Carmela Benson, Keith Dunn> ;Clinical Infectious Diseases. 2020 Dec 15
• 3 citations
  Human Immunodeficiency Virus in the State of Texas of the United States: Past Reflections, Present Shortcomings, and Future Needs of the Public Health Response.
  Ume L. Abbas, Camden J. Hallmark, Marlene McNeese, Vagish Hemmige, Joseph Gathe, Victoria Williams, Brandon Wolf, Maria C. Rodriguez-Barradas> ;Open Forum Infectious Diseases. 2020 Oct 1
• 3 citations
  Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients wi...
  Chan-Loi Yong, Joseph Gathe, Gabriele Knecht, Catherine Orrell, Josep Mallolas, Daniel Podzamczer, Benoit Trottier, Wei Zhang, John P. Sabo, Richard Vinisko, Murray Dr...> ;HIV Clinical Trials. 2017 Nov 1
• 72 citations
  Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat,...
  Chloe Orkin, Jean-Michel Molina, Eugenia Negredo, Jose R. Arribas, Joseph Gathe, Joseph J. Eron, Erika Van Landuyt, Erkki Lathouwers, Veerle Hufkens, Romana Petrovic, ...> ;The Lancet. HIV. 2018 Jan 1
• Fatal Relapse of Myelodysplastic Syndrome in a Patient with HIV/Hepatitis C Coinfection Treated with Simeprevir/Sofosbuvir.
  Efemena Michael Diejomaoh, Joseph Gathe, Carl Mayberry, John Benjamin Clemmons, Bernie Miguel, Alan Glombicki, Benjamin Daquioag> ;Journal of the International Association of Providers of AIDS Care. 2017 Jan 16
• 58 citations
  A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus.
  Melanie A. Thompson, Michael S. Saag, Edwin DeJesus, Joseph Gathe, J. Lalezari, Alan L. Landay, Jerry Cade, Jeffrey Enejosa, Eric Lefebvre, Judith Feinberg> ;AIDS. 2016 Mar 27
• 65 citations
  Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologica...
  Jean-Guy Baril, Jonathan B. Angel, M. John Gill, Joseph Gathe, Pedro Cahn, Jean van Wyk, Sharon Walmsley> ;Plos One. 2016 Feb 5
• 8 citations
  Fecal Transplantation for Clostridium Difficile-"All Stool May Not Be Created Equal"
  Joseph Gathe, Efemena Michael Diejomaoh, Carl Mayberry, John Benjamin Clemmons> ;Journal of the International Association of Providers of AIDS Care. 2016 Jan 28
• 11 citations
  Patient-Reported Symptoms over 48 Weeks in a Randomized, Open-Label, Phase 3b Non-inferiority Trial of Adults with HIV Switching to Coformulated Elvitegravir, Cobicist...
  Joseph Gathe, Jose R. Arribas, Jan van Lunzen, Will Garner, Rebecca M. Speck, Randall Bender, Sanatan Shreay, Thai Nguyen> ;The Patient. 2015 Aug 19
• 327 citations
  Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1
  David L. Wyles, Peter Ruane, Mark S. Sulkowski, Douglas T. Dieterich, Anne F Luetkemeyer, Timothy R. Morgan, Kenneth E. Sherman, Robin Dretler, Dawn Fishbein, Joseph G...> ;The New England Journal of Medicine. 2015 Aug 19
• 254 citations
  Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1: A Randomized Trial
  , , , , , , , , , , , , , , , , , , , , , , , > ;JAMA. 2015 Mar 24
• 95 citations
  Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine an...
  Jose R. Arribas, Gilles Pialoux, Joseph Gathe, Giovanni Di Perri, Jacques Reynes, Pablo Tebas, Thai Nguyen, Ramin Ebrahimi, Kirsten L. White, David Piontkowsky> ;The Lancet. Infectious Diseases. 2014 Jul 1
• 64 citations
  A Randomized, Double-blind Comparison of Single-tablet Regimen Elvitegravir/cobicistat/emtricitabine/tenofovir Df vs Ritonavir-boosted Atazanavir Plus Emtricitabine/te...
  Nathan Clumeck, Jean Michel Molina, Keith Henry, Joseph Gathe, Jürgen K. Rockstroh, Edwin DeJesus, Xuelian Wei, Kirsten L. White, Marshall W. Fordyce, Martin S. Rhee, ...> ;Journal of Acquired Immune Deficiency Syndromes. 2014 Mar 1
• 14 citations
  Safety and efficacy of ombitasvir - 450/r and dasabuvir and ribavirin in HCV/HIV-1 co-infected patients receiving atazanavir or raltegravir ART regimens.
  Joseph J. Eron, J. Lalezari, Jihad Slim, Joseph Gathe, Peter Ruane, Chia Wang, Richard Elion, Gary Blick, Amit Khatri, Yiran B Hu, Krystal Gibbons, Linda M Fredrick, M...> ;Journal of the International AIDS Society. 2014 Nov 2
• 1 citations
  Long-term safety study of fosamprenavir-containing regimens in HIV-1-infected patients.
  Robin Wood, Joseph Gathe, Naomi Givens, Sangeeta Sedani, Katharine Cheng, Jörg Sievers> ;HIV Clinical Trials. 2013 Sep 1
• 104 citations
  A randomized, double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabin...
  Jürgen K. Rockstroh, Edwin DeJesus, Keith Henry, Jean Michel Molina, Joseph Gathe, Srinivasan Ramanathan, Xuelian Wei, Andrew Plummer, Michael E. Abram, Andrew K. Chen...> ;Journal of Acquired Immune Deficiency Syndromes. 2013 Apr 15
• VERxVE 144 week results: nevirapine extended-release (NVP XR) QD versus NVP immediate-release (IR) BID with FTC/TDF in treatment-naïve HIV-1 patients.
  Brinson, C., Bogner, J., Nelson, M., Podzamczer, D., Quinson, A., Drulak, M., Gathe, J.> ;J Int AIDS Soc. 2012 Dec 14
• 269 citations
  Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenof...
  Edwin DeJesus, Jürgen K. Rockstroh, Keith Henry, Jean-Michel Molina, Joseph Gathe, Srinivasan Ramanathan, Xuelian Wei, Kitty Yale, Javier Szwarcberg, Kirsten L. White,...> ;Lancet. 2012 Jun 30
• 20 citations
  Risk factors for vitamin D deficiency in HIV-infected patients in the south central United States.
  Rustin D. Crutchley, Joseph Gathe, Carl Mayberry, Angel Trieu, Susan Abughosh, Kevin W. Garey> ;AIDS Research and Human Retroviruses. 2011 Oct 19
• 52 citations
  Efficacy and safety of nevirapine extended-release once daily versus nevirapine immediate-release twice-daily in treatment-naive HIV-1-infected patients.
  Joseph Gathe, Jaime Andrade-Villanueva, Steven Santiago, Andrzej Horban, Mark T. Nelson, Pedro Cahn, Johannes R. Bogner, David Spencer, Daniel Podzamczer, Chan-Loi Yon...> ;Antiviral Therapy. 2011 Jan 1
• 3 citations
  Lopinavir/ritonavir dosage form affects quality of life during monotherapy in HIV-positive adults.
  Rosa F. Yeh, Bryan A. Lipman, Carl Mayberry, Bernie Miguel, John J. Nemecek, Joseph Gathe> ;Journal of the International Association of Physicians in AIDS Care. 2010 Sep 1
• 14 citations
  Cord Blood Stem Cell Therapy for Acquired Immune Deficiency Syndrome
  Gabriel Gonzalez, Elizabeth J. Shpall, Joseph C. Gathe, Richard R. Behringer> ;Stem Cells and Development. 2009 Jan 1
• 9 citations
  Modulation of K65R selection by zidovudine inclusion: analysis of HIV resistance selection in subjects with virologic failure receiving once-daily abacavir/lamivudine/...
  Lisa L. Ross, Richard Elion, Randall Lanier, Edwin DeJesus, Calvin J. Cohen, Robert R. Redfield, Joseph Gathe, Ricky Hsu, Linda Yau, Denise Paulsen, Belinda Ha> ;AIDS Research and Human Retroviruses. 2009 Jul 21
• Join now to see all